[Polypeptide bioregulators in the treatment of different-type abiotrophy of the retina].
The efficiency of retinalamin was studied in 33 patients, aged 4 to 7, with 5 types of retinal abiotrophy. The experimental group comprised children with retinal abiotrophy of Franceschetti type (36%) and mixed type (39%). The pathological process was stabilized during 18 months in all cases of developed disease. The visual acuity improved in 82% of patients after treatment by retinalamin; visual fields enlarged and central scotomas reduced in 54% of cases. Parameters of elctroretinography improved in 37% of cases.